Education＆ScienceWebinars
APSR 1st Grand Rounds 2026
Lung Cancer: from screening to diagnosis to treatmentShare:
Thursday 12 March 2026
- 17:30 - 18:30 Kuala Lumpur, Singapore, Hong Kong time (UTC+8)
- 18:30 - 19:30 Tokyo, Seoul time (UTC+9)
This program is recognised as an accredited CME activity in Bangladesh, Hong Kong, Indonesia, Malaysia, Mongolia, the Philippines, Singapore, Sri Lanka and Taiwan.
This webinar has ended.
OUTLINE
This is the first of a regular series of Grand Rounds in 2026, where 3 cases will be presented on clinical problems in Respiratory & Critical Care Medicine. The emphasis is on teaching points which we hope the audience will find educational and useful. This Grand Round will cover Clinical Teaching Cases in Respiratory Medicine from the Asia Pacific.
TOPICS
- “Product and by-products of lung screening” – Dr Alex Leung
- “Durable Disease Control Beyond 7 years in EGFR Exon 19 Deletion Lung Adenocarcinoma : A case report.” – Dr Noni Novisari Soeroso
- “A patient with pneumonitis on immunotherapy” – Dr Tracy Leong
FORMAT
- Welcome and Introduction
- Presentation
Three 15-minute presentations, each followed by 4-minute Q&A - Closing Remarks
CHAIRPERSONS & SPEAKERS
Dr Alex Leung
SPEAKER
Resident, Division of Respiratory Medicine and Critical Care Medicine,
Department of Medicine,
Queen Mary Hospital
Hong Kong
Dr Noni Novisari Soeroso, FAPSR
SPEAKER
Head-Elect of the APSR Lung Cancer Assembly
Thoracic Oncologic Division, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Sumatera Utara, Prof. Chairuddin P. Lubis USU Hospital
Indonesia
Dr Tracy Leong, FAPSR
SPEAKER
Deputy Head of the APSR Lung Cancer Assembly
Director of Interventional Pulmonology,
Austin Health, Senior Clinician Scientist, Olivia Newton-John Cancer Research Institute
Australia
Dr Grace Lam, FAPSR
CO-CHAIRPERSON
Deputy chairperson of the ASPR Education Committee
Hong Kong
Dr David Chi Leung Lam, FAPSR
CO-CHAIRPERSON
Head of the APSR Lung Cancer Assembly
Hong Kong
This program is recognised as an accredited CME activity in Bangladesh, Hong Kong, Indonesia, Malaysia, Mongolia, the Philippines, Singapore, Sri Lanka and Taiwan.
